• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SWK Holdings Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

    6/16/25 4:46:50 PM ET
    $SWKH
    Diversified Financial Services
    Finance
    Get the next $SWKH alert in real time by email
    swkh-20250616
    0001089907FALSE00010899072025-06-162025-06-160001089907us-gaap:CommonStockMember2025-06-162025-06-160001089907us-gaap:SeniorNotesMember2025-06-162025-06-16


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of Earliest Event Reported): June 16, 2025
     
    SWK HOLDINGS CORPORATION
    (Exact Name of the Registrant as Specified in Its Charter)
     
    Delaware
    (State or Other Jurisdiction of Incorporation)
     
    F11.001-39184
    77-0435679
    (Commission File Number)(IRS Employer Identification No.)
      
    5956 Sherry Lane, Suite 650, Dallas, TX
    75225
    (Address of Principal Executive Offices)(Zip Code)
     
    (972) 687-7250
    (Registrant’s Telephone Number, Including Area Code)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each classTrading Symbol(s)Name of each exchange on
    which registered
    Common Stock, par value
    $0.001 per share
    SWKHThe Nasdaq Stock Market LLC
    9.00% Senior Notes due 2027SWKHLThe Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).           Emerging growth company   
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
     





    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 
    On June 13, 2025, at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of SWK Holdings Corporation (the “Company”), the Company’s stockholders approved the amendment (the “Plan Amendment”) to the Company’s 2010 Equity Incentive Plan (the “Plan”) to extend the date of termination of the Plan to June 13, 2030. The Plan Amendment previously had been approved, subject to stockholder approval, by the Board of Directors of the Company. The Plan Amendment became effective immediately upon stockholder approval at the Annual Meeting.
    A description of the material terms of the Plan Amendment is contained in the Company’s Definitive Proxy Statement for the Annual Meeting filed with the Securities and Exchange Commission on April 29, 2025 (the “Proxy Statement”). The foregoing description of the Plan Amendment and the summary contained in the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Plan Amendment, which will be filed with the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2025.
    Item 5.07 Submission of Matters to a Vote of Security Holders. 
    On June 13, 2025, the Company held its Annual Meeting virtually. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting, which are described in detail in the Proxy Statement. 
     Proposal 1 – Election of Directors. Each of Jerry Albright, Laurie L. Dotter and Robert K. Hatcher were elected to the Board of Directors, by a plurality of votes, to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors have been elected and qualified, or their earlier resignation, death or removal, with the voting results being as follows:
    NomineeForWithhold AuthorityBroker Non-Votes
    Jerry Albright10,463,066433,245385,315
    Laurie L. Dotter10,474,781421,530385,315
    Robert K. Hatcher10,488,381407,930385,315
    Proposal 2 – Ratification of Independent Registered Public Accountants. The appointment of BPM LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year was ratified, as follows:
     
    ForAgainstAbstain
    11,226,98754,500139
    Proposal 3 – Approval, on an advisory basis, of the compensation paid to certain executive officers. The stockholders approved, on an advisory basis, the compensation paid to certain executive officers, as follows:
     
    ForAgainstAbstainBroker Non-Votes
    10,385,696420,20390,412385,315
    Proposal 4 – Approval of an amendment to the Company’s 2010 Equity Incentive Plan, as amended. The stockholders approved an amendment to the Company’s 2010 Equity Incentive Plan as follows:
    ForAgainstAbstainBroker Non-Votes
    9,696,1921,163,71436,405385,315
     



    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     
    SWK HOLDINGS CORPORATION
      
    By: /s/ Joe D. Staggs
     Joe D. Staggs
     President and Chief Executive Officer
     
    Date: June 16, 2025
      
     
     

    Get the next $SWKH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SWKH

    DatePrice TargetRatingAnalyst
    12/28/2022$26.00Buy
    Lake Street
    4/18/2022$26.00Buy
    Lake Street
    More analyst ratings

    $SWKH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hatcher Robert K. was granted 3,858 shares, increasing direct ownership by 30% to 16,662 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      6/18/25 8:16:45 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Director Albright Jerry was granted 3,858 shares, increasing direct ownership by 55% to 10,832 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      6/18/25 8:16:24 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Director Dotter Laurie L. was granted 3,858 shares, increasing direct ownership by 30% to 16,791 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      6/18/25 8:15:58 PM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ImpediMed Secures $15m Growth Capital Funding

      New round will help fuel commercialization efforts in support of ImpediMed's platform technology for the detection and monitoring of lymphedema. CARLSBAD, Calif., Feb. 7, 2025 /PRNewswire/ -- ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, today announced an agreement for a five-year $15 million growth capital facility with SWK Holdings (NASDAQ:SWKH), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies. Funds raised will provide ImpediMed with funding flexibility and will be used to support growth and commercialization activities. Armentum Partners acted as the Company's exclusiv

      2/7/25 11:00:00 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

      January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists

      1/22/25 8:30:00 AM ET
      $BDRX
      $JNJ
      $SWKH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Diversified Financial Services
      Finance
    • SWK Holdings Provides Portfolio Update

      DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update for material events occurring since September 30, 2024.OriginationsIn November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company's launch of EmrosiTM.In November, as part of a broader amendment SWK advanced $0.6M to existing borrower Biotricity. On amendment closing, SWK received 600,000 warrants to purchase Biotricity stock at $0.50 per share.In December, SWK closed an $8.0M senior secured term loan with Triple

      1/6/25 7:35:00 AM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street resumed coverage on SWK Holdings with a new price target

      Lake Street resumed coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

      12/28/22 9:18:49 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Lake Street initiated coverage on SWK Holdings with a new price target

      Lake Street initiated coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

      4/18/22 8:44:23 AM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    SEC Filings

    See more
    • SWK Holdings Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - SWK Holdings Corp (0001089907) (Filer)

      6/16/25 4:46:50 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Corporation filed SEC Form 8-K: Other Events

      8-K - SWK Holdings Corp (0001089907) (Filer)

      5/19/25 8:47:29 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SWK Holdings Corp (0001089907) (Filer)

      5/15/25 4:23:24 PM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    Leadership Updates

    Live Leadership Updates

    See more
    • Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

      January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists

      1/22/25 8:30:00 AM ET
      $BDRX
      $JNJ
      $SWKH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Diversified Financial Services
      Finance
    • SWK Holdings Appoints Chief Financial Officer

      Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of Adam C. Rice, CPA, as Chief Financial Officer (CFO) of the company and the promotion of Courtney Baker, CPA, to Controller.With over 18 years of senior-level finance and accounting leadership experience, Rice has led financial operations management, corporate financial planning and analysis, strategic planning and financial statement reporting. He was previously CFO of Park Cities Asset Management, an SEC

      7/8/24 5:00:00 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Stanley Black & Decker Appoints Chris Nelson Chief Operating Officer and Executive Vice President and President of Tools & Outdoor

      NEW BRITAIN, Conn., May 2, 2023 /PRNewswire/ -- Stanley Black & Decker (NYSE:SWK) today announced the appointment of Chris Nelson as Chief Operating Officer of the company, and Executive Vice President and President of Tools & Outdoor, effective June 14, 2023. Nelson joins Stanley Black & Decker from Carrier Corporation and brings more than 25 years of leadership experience in general management, product development and innovation, and growth transformation. Nelson will report to Donald Allan Jr., President and CEO of Stanley Black & Decker. He will assume the role of President, Tools & Outdoor, from current Acting Co-Presidents Robert Raff and John Wyatt. Raff will continue to serve as Chie

      5/2/23 4:36:00 PM ET
      $SWK
      $SWKH
      Industrial Machinery/Components
      Consumer Discretionary
      Diversified Financial Services
      Finance

    $SWKH
    Financials

    Live finance-specific insights

    See more
    • SWK Holdings Corporation Announces Financial Results for Third Quarter 2024

      Conference Call Scheduled for Friday, November 15, 2024, at 09:00 a.m. CSTCorporate HighlightsThird quarter 2024 GAAP net income was $3.5 million, compared with GAAP net income of $4.5 million for the third quarter 2023.Third quarter 2024 finance receivables segment adjusted non-GAAP net income was $5.0 million, compared with adjusted non-GAAP net income of $5.8 million for the third quarter 2023.As of September 30, 2024, net finance receivables were $255.9 million, a 14.4% increase from September 30, 2023.The third quarter 2024 effective yield was 14.6%, a 60 basis points increase from third quarter 2023.As of September 30, 2024, GAAP book value per share was $22.94, a 3.7% increase from $2

      11/14/24 4:15:00 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Provides Portfolio Update

      Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results

      10/17/24 4:15:00 PM ET
      $BTCY
      $DERM
      $ELUT
      $ETON
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Biotechnology: Biological Products (No Diagnostic Substances)
    • SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

      DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies."During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month," said SWK President and CEO Jody Staggs."Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of st

      7/17/24 4:15:00 PM ET
      $BIOL
      $BTCY
      $DERM
      $ELUT
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Biotechnology: Biological Products (No Diagnostic Substances)

    $SWKH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by SWK Holdings Corporation

      SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

      11/14/24 11:49:47 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Amendment: SEC Form SC 13D/A filed by SWK Holdings Corporation

      SC 13D/A - SWK Holdings Corp (0001089907) (Subject)

      10/25/24 4:05:56 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SEC Form SC 13G/A filed by SWK Holdings Corporation (Amendment)

      SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

      2/14/24 2:14:12 PM ET
      $SWKH
      Diversified Financial Services
      Finance